A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...
Main Authors: | Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2009
|
פריטים דומים
-
Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
מאת: Yin, H, et al.
יצא לאור: (2010) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
מאת: Gang Han, et al.
יצא לאור: (2016-03-01) -
Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
מאת: Annemieke Aartsma-Rus
יצא לאור: (2022-12-01) -
Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
מאת: Yin, HF, et al.
יצא לאור: (2016) -
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
מאת: Betts, C, et al.
יצא לאור: (2018)